[1] |
Sayagués JM, Del Carmen S, Del Mar Abad M, et al. Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients[J]. Oncotarget, 2018, 9(35): 24081-24096.
|
[2] |
李天翔,吴力群,蒋晓,等. 中性粒细胞与淋巴细胞比值在预测HBV相关肝细胞癌术后患者预后中的价值[J/CD]. 中华肝脏外科手术学电子杂志, 2014, 3(1): 12-15.
|
[3] |
Hirahara T, Arigami T, Yanagita S, et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer[J]. BMC Cancer, 2019, 19(1): 672.
|
[4] |
国家卫生计生委医政医管局,中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J/CD]. 中华普通外科学文献(电子版), 2018, 12(3): 145-159.
|
[5] |
方旭东,方晓明,陈达伟,等. NLR和PLR预测经TACE治疗的原发性肝癌患者预后的价值初步分析[J]. 实用肝脏病杂志, 2018, 21(3): 431-434.
|
[6] |
王彦,吴砚铭,王彦文,等. C反应蛋白/白蛋白比值与肺癌患者预后关系的Meta分析[J]. 华西医学, 2019, 34(1): 50-57.
|
[7] |
Ying HQ, Deng QW, He BS, et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients[J]. Med Oncol, 2014, 31(12): 305.
|
[8] |
Okugawa Y, Toiyama Y, Yamamoto A, et al. Close relationship between immunological/inflammatory markers and myopenia and myosteatosis in patients with colorectal cancer: A propensity score matching analysis[J]. JPEN J Parenter Enteral Nutr, 2019, 43(4): 508-515.
|
[9] |
Shibutani M, Maeda K, Nagahara H, et al. The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer[J]. World J Surg Oncol, 2015, 13: 194.
|
[10] |
Shirai Y, Shiba H, Sakamoto T, et al. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection[J]. Surgery, 2015, 158(2): 360-365.
|
[11] |
夏志刚,甘志明,向立历,等. NLR和PLR与结直肠癌患者TNM分期及预后的相关性研究[J]. 中国普外基础与临床杂志, 2017, 24(8): 963-969.
|
[12] |
Otowa Y, Nakamura T, Yamazaki Y, et al. Meaning of C-reactive protein around esophagectomy for Stage esophageal cancer[J]. Surg Today, 2019, 49(1): 90-95.
|
[13] |
Mori K, Toiyama Y, Saigusa S. Systemic analysis of predictive biomarkers for recurrence in colorectal cancer patients treated with curative surgery[J]. Dig Dis Sci, 2015, 60(8): 2477-2487.
|
[14] |
陈英英,张佳和,张湾,等. C反应蛋白/白蛋白比率预测结直肠癌病人预后关系[J]. 南方医科大学学报, 2017, 37(5): 622-627.
|